HomeNewscoronavirusCOVID-19 patients infect half of household: US govt study

COVID-19 patients infect half of household: US govt study

Forty percent of index patients reported sleeping in the same room with one or more household members before illness onset and 30 percent after illness onset.

October 31, 2020 / 10:19 IST
Story continues below Advertisement

The paper by the Centers of Disease Control and Prevention (CDC) is the latest to attempt to quantify the household transmission rate of the disease, with previous research varying widely but generally suggesting that adults are bigger drivers than children.

The new research by the CDC involved finding cases of "index" or initial patients with lab-confirmed coronavirus infection in Nashville, Tennessee, and Marshfield, Wisconsin, starting in April 2020.

Story continues below Advertisement

Both the index patients and their household members were trained remotely to complete symptom diaries and obtain self-collected specimens, which were either nasal swabs only or nasal swabs and saliva samples, for 14 days.

A total of 191 enrolled household contacts of 101 index patients reported having no symptoms on the day of their index patient's illness onset.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show